Ultralife Corporation - Common Stock (ULBI)

Global supply chains continue to navigate a tumultuous landscape in November 2025, grappling with a complex interplay of geopolitical tensions, economic volatility, and environmental challenges. These disruptions, far from being transient, are now widely expected to persist for at least the next one to two years, fundamentally reshaping operational strategies

Ultralife Corp (ULBI) stock plunges after Q3 2025 earnings and revenue fall significantly short of analyst expectations.

The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Ultralife Corp (ULBI) Q2 2025 earnings miss estimates with $48.56M revenue & $0.07 EPS, triggering a 20% pre-market drop. Analysts eye future recovery.

The battery solutions firm reported an adjusted income of $0.01 per share, while analysts expected $0.15 in earnings.

U.S. stock futures were swinging between gains and losses on Tuesday after a mixed session on Monday. Futures of major benchmark indices were mixed in premarket trading. President Donald Trump‘s “Liberation Day”, the term he’s used for April 2nd, the day of incoming reciprocal tariffs, preceded a drop in stock prices.